HomeABEO • NASDAQ
add
Abeona Therapeutics Inc
Previous close
$5.93
Year range
$3.05 - $9.01
Market cap
256.85M USD
Avg Volume
228.26K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
BBY
0.00%
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 17.64M | 32.37% |
Net income | 7.41M | 144.47% |
Net profit margin | — | — |
Earnings per share | -0.44 | 13.12% |
EBITDA | -17.38M | -57.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 122.71M | 233.70% |
Total assets | 134.00M | 150.24% |
Total liabilities | 60.76M | 37.46% |
Total equity | 73.24M | — |
Shares outstanding | 43.31M | — |
Price to book | 3.37 | — |
Return on assets | -42.77% | — |
Return on capital | -80.69% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | 7.41M | 144.47% |
Cash from operations | -12.68M | -23.34% |
Cash from investing | -44.13M | -946.90% |
Cash from financing | 73.68M | 1,013.39% |
Net change in cash | 16.87M | 991.78% |
Free cash flow | -7.37M | 9.77% |
About
Founded
1974
Headquarters
Website
Employees
84